It’s only a matter of time before generative AI (GenAI) will be charged with automatically generating entire regulatory submissions from scratch – and bolstering their impact based on what’s gone before.
Already in its relatively short existence, GenAI technology has come a long way.
Today, it is actively transforming everyday pharma regulatory and safety processes, based on its ability to very efficiently digest, assess and summarise key insights and findings.
Check out the rest of the feature here
